Skip to main content
Erschienen in: Neurological Sciences 5/2013

01.05.2013 | Original Article

Validation of the Italian version of the Movement Disorder Society—Unified Parkinson’s Disease Rating Scale

verfasst von: Angelo Antonini, Giovanni Abbruzzese, Luigi Ferini-Strambi, Barbara Tilley, Jing Huang, Glenn T. Stebbins, Christopher G. Goetz, Paolo Barone, Monica Bandettini di Poggio, Giovanni Fabbrini, Flavio Di Stasio, Michele Tinazzi, Tommaso Bovi, Silvia Ramat, Sara Meoni, Gianni Pezzoli, Margherita Canesi, Paolo Martinelli, Cesa Lorella Maria Scaglione, Aroldo Rossi, Nicola Tambasco, Gabriella Santangelo, Marina Picillo, Letterio Morgante, Francesca Morgante, Rocco Quatrale, MariaChiara Sensi, Manuela Pilleri, Roberta Biundo, Giampietro Nordera, Antonella Caria, Claudio Pacchetti, Roberta Zangaglia, Leonardo Lopiano, Maurizio Zibetti, Mario Zappia, Alessandra Nicoletti, Aldo Quattrone, Maria Salsone, Gianni Cossu, Daniela Murgia, Alberto Albanese, Francesca Del Sorbo, MDS-UPDRS Italian Validation Study Group

Erschienen in: Neurological Sciences | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Abstract

The Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) has been available in English since 2008. As part of this process, the MDS-UPDRS organizing team developed guidelines for development of official non-English translations. We present here the formal process for completing officially approved non-English versions of the MDS-UPDRS and specifically focus on the first of these versions in Italian. The MDS-UPDRS was translated into Italian and tested in 377 native-Italian speaking PD patients. Confirmatory and exploratory factor analyses determined whether the factor structure for the English-language MDS-UPDRS could be confirmed in data collected using the Italian translation. To be designated an ‘Official MDS translation,’ the Comparative Fit Index (CFI) had to be ≥0.90 relative to the English-language version. For all four parts of the Italian MDS-UPDRS, the CFI, in comparison with the English-language data, was ≥0.94. Exploratory factor analyses revealed some differences between the two datasets, however these differences were considered to be within an acceptable range. The Italian version of the MDS-UPDRS reaches the criterion to be designated as an Official Translation and is now available for use. This protocol will serve as outline for further validation of this in multiple languages.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Fahn S, Elton RL. Unified Parkinson’s Disease Rating Scale. In: Recent developments in Parkinson’s disease: MacMillan Healthcare Information, 1987:153–164 Fahn S, Elton RL. Unified Parkinson’s Disease Rating Scale. In: Recent developments in Parkinson’s disease: MacMillan Healthcare Information, 1987:153–164
2.
Zurück zum Zitat Movement Disorder Society Task Force on Rating Scales for Parkinson’s Disease (2003) The Unified Parkinson’s Disease Rating Scale (UPDRS): status and recommendations. Mov Disord 18:738–750CrossRef Movement Disorder Society Task Force on Rating Scales for Parkinson’s Disease (2003) The Unified Parkinson’s Disease Rating Scale (UPDRS): status and recommendations. Mov Disord 18:738–750CrossRef
3.
Zurück zum Zitat Goetz CG, Tilley BC, Shaftman SR et al (2008) Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23:2129–2170PubMedCrossRef Goetz CG, Tilley BC, Shaftman SR et al (2008) Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23:2129–2170PubMedCrossRef
4.
Zurück zum Zitat Goetz CG, Fahn S, Martinez-Martin P et al (2006) Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan. Mov Disord 22(1):41–47CrossRef Goetz CG, Fahn S, Martinez-Martin P et al (2006) Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan. Mov Disord 22(1):41–47CrossRef
5.
Zurück zum Zitat Hatcher L (1994) A step-by-step approach to using the SAS system for factor analysis and structural equation modeling. SAS Institue, Cary Hatcher L (1994) A step-by-step approach to using the SAS system for factor analysis and structural equation modeling. SAS Institue, Cary
6.
Zurück zum Zitat Gorsuch R (1983) Factor analysis, 2nd edn. Lawrence Erlbaum Associations, Hillsdale Gorsuch R (1983) Factor analysis, 2nd edn. Lawrence Erlbaum Associations, Hillsdale
7.
Zurück zum Zitat Goetz CG, Stebbins GT, Chmura TA, Fahn S, Poewe W, Tanner CM (2010) Teaching program for the Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale: (MDS-UPDRS). Mov Disord 25:1190–1194PubMedCrossRef Goetz CG, Stebbins GT, Chmura TA, Fahn S, Poewe W, Tanner CM (2010) Teaching program for the Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale: (MDS-UPDRS). Mov Disord 25:1190–1194PubMedCrossRef
Metadaten
Titel
Validation of the Italian version of the Movement Disorder Society—Unified Parkinson’s Disease Rating Scale
verfasst von
Angelo Antonini
Giovanni Abbruzzese
Luigi Ferini-Strambi
Barbara Tilley
Jing Huang
Glenn T. Stebbins
Christopher G. Goetz
Paolo Barone
Monica Bandettini di Poggio
Giovanni Fabbrini
Flavio Di Stasio
Michele Tinazzi
Tommaso Bovi
Silvia Ramat
Sara Meoni
Gianni Pezzoli
Margherita Canesi
Paolo Martinelli
Cesa Lorella Maria Scaglione
Aroldo Rossi
Nicola Tambasco
Gabriella Santangelo
Marina Picillo
Letterio Morgante
Francesca Morgante
Rocco Quatrale
MariaChiara Sensi
Manuela Pilleri
Roberta Biundo
Giampietro Nordera
Antonella Caria
Claudio Pacchetti
Roberta Zangaglia
Leonardo Lopiano
Maurizio Zibetti
Mario Zappia
Alessandra Nicoletti
Aldo Quattrone
Maria Salsone
Gianni Cossu
Daniela Murgia
Alberto Albanese
Francesca Del Sorbo
MDS-UPDRS Italian Validation Study Group
Publikationsdatum
01.05.2013
Verlag
Springer Milan
Erschienen in
Neurological Sciences / Ausgabe 5/2013
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-012-1112-z

Weitere Artikel der Ausgabe 5/2013

Neurological Sciences 5/2013 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.